Vice President, Global Head Rare Disease @ (June 2025 - October 2025)
Executive Director, Global Head of Rare Disease @ (August 2022 - June 2025)
Volunteer and Mentor @ (February 2026 - Present)
European Regional Task Force - Member @ (February 2026 - Present)
ERTC Member @ (August 2022 - Present)
Member @ (October 2025 - Present)
UK Platform for Nucleic Acid Therapies - Collaborator @ (August 2024 - Present)
Global Genes Corporate Alliance Member @ (March 2023 - Present)
Co-Lead, Global Genes Mental Health Working Group @ (March 2023 - March 2025)
Community Congress Member @ (October 2022 - Present)
Portfolio Director - Cell and Gene Therapy and Rare Disease @ (January 2021 - January 2022)
VP Clinical Operations Europe - Joint Interim Cover @ (January 2021 - January 2022)
Global Head of Cell and Gene Center of Excellence @ (January 2020 - January 2022)
Project Director - Cell and Gene Therapy and Rare Disease @ (January 2020 - January 2021)
Senior Clinical Project Manager (Rare Disease and Cell and Gene Therapy) @ The CLINICAL TRIAL Company Ltd (January 2018 - January 2020)
Head of Project Management - Interim Cover @ The CLINICAL TRIAL Company Ltd (January 2018 - January 2019)
Clinical Project Manager (Rare Disease and Cell and Gene Therapy) @ The CLINICAL TRIAL Company Ltd (January 2015 - January 2018)
Local Project Manager @ Scope International AG (January 2013 - January 2015)
Clinical Research Scientist (Clinical Study Manager) @ GlaxoSmithKline (January 2011 - January 2012)
Rachel Smith Education
University of Warwick
Bachelor's degree (Biochemistry)
Rachel Smith Skills
Biotech
Budget Management
Business Process Development
Business Strategy
CRO
CTMS
Clinical Development
Clinical Monitoring
Clinical Operations
Clinical Research
Clinical Trial Management
Clinical Trial Management System (CTMS)
Clinical Trials
Cross-functional Collaborations
Cross-functional Team Leadership
Customer Escalation Management
Executive Leadership
Gene Therapy
Global Cross-Functional Team Leadership
Global Drug Development
Global Leadership
Good Clinical Practice (GCP)
Healthcare
ICH-GCP
Immunology
International Project Management
Management Of International Teams
Market Access
Marketing Strategy
Mergers & Acquisitions (M&A)
Neuroscience
P&L Management
Patient Advocacy
Pediatrics
Problem Solving
Project Management
Protocol Writing
Public Policy
Rare Diseases
Regulatory Affairs
Regulatory Strategy
Regulatory Submissions
Respiratory Disease
Sales Strategy
Stakeholder Engagement
Strategic Leadership
Team Coordination
Time Management
Microsoft Office 2007
Group Presentations
Live Meeting
Meeting Management
Document Review
Site Initiation
Study Managers
Clinical Protocols
Trial Management
Microsoft Office
Pharmaceutical Industry
GCP
Science
Data Analysis
Microsoft Excel
Clinical Trial Management System Ctms
Ich Gcp
Biochemistry
Chemistry
Clinical Trial Management System
Rachel Smith Summary
Rachel Smith, based in United Kingdom, is currently a Vice President, Rare and Genetic Disease at Parexel. Rachel Smith brings experience from previous roles at Parexel, Stemettes and EURORDIS-Rare Diseases Europe. Rachel Smith holds a Bachelor's degree in Biochemistry @ University of Warwick. With a robust skill set that includes Biotech , Budget Management, Business Process Development, Business Strategy, CRO and more. Rachel Smith has 1 emails on RocketReach.
Looking for a different Rachel Smith?
Find contact details for 700 million professionals.